Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 2/20 | 0.61 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.61 |
| ▸ | CTSL | P07711 | 5/20 | 0.60 |
| ▸ | CTSB | P07858 | 4/20 | 0.60 |
| ▸ | CTSS | P25774 | 1/20 | 0.60 |
| ▸ | CTSK | P43235 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3491951 | 0.90 | CTSL (0.61) | TACR1CAPN1CTSLCTSBCTSS | |
| SCHEMBL18328618 | 0.88 | TACR1 (0.64) | TACR1CTSLCTSBCTSSCTSK | |
| SCHEMBL9195401 | 0.88 | TACR1 (0.64) | TACR1CTSLCTSBCTSSCTSK | |
| SCHEMBL7740137 | 0.88 | CAPN1 (0.69) | CAPN1CTSLCTSBCTSSCTSK | |
| Alanine SCHEMBL4504083 | 0.87 | CAPN1 (0.56) | TACR1CAPN1CTSLCTSBCTSS | |
| SCHEMBL3165013 | 0.85 | CTSK (0.67) | CAPN1CTSLCTSBCTSSCTSK | |
| SCHEMBL12052836 | 0.84 | TACR1 (0.70) | TACR1CAPN1CTSLCTSBCTSS | |
| SCHEMBL10049956 | 0.84 | TACR1 (0.70) | TACR1CAPN1CTSLCTSBCTSS | |
| SCHEMBL16095807 | 0.84 | TACR1 (0.70) | TACR1CAPN1CTSLCTSBCTSS | |
| SCHEMBL8100557 | 0.84 | TACR1 (0.70) | TACR1CAPN1CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170037471-A1 | METHODS FOR DIAGNOSING & TREATING COPPER-DEPENDENT DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-02-09 | — | — | US | disclosed |
| US-20160175351-A1 | CANCER TREATMENT | DUKE UNIVERSITY | 2016-06-23 | — | — | US | disclosed |
| EP-3013332-A1 | CANCER TREATMENT | Duke University (US) | 2016-05-04 | — | — | EP | disclosed |
| WO-2015100300-A2 | METHODS FOR DIAGNOSING AND TREATING COPPER-DEPENDENT DISEASES | DUKE UNIVERSITY (US) | 2015-07-02 | — | — | WO | disclosed |
| WO-2014209957-A1 | CANCER TREATMENT | DUKE UNIVERSITY (US) | 2014-12-31 | — | — | WO | disclosed |
| EP-1626732-B1 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | CHIESI FARMA SPA (IT) | 2013-04-03 | — | — | EP | disclosed |
| US-20120329721-A1 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-12-27 | — | — | US | disclosed |
| US-20100113369-A1 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | THERAPTOSIS S.A. (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20060241034-A1 | Means for preventing and treating cellular death and their biological applications | THERAPTOSIS S.A. (FR) | 2006-10-26 | — | — | US | disclosed |
| EP-1626732-A2 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | Theraptosis S.A. (FR) | 2006-02-22 | — | — | EP | disclosed |
| WO-2004103389-A2 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | THERAPTOSIS SA (FR) | 2004-12-02 | — | — | WO | disclosed |